Dysbiosis in phylogenetically diverse species associated with type 2 diabetes
Jun 26, 2024
Within-species phylogenetic diversity was identified for strains of 27 species that explain inter-individual differences in type 2 diabetes risk.
Endocrine Society, June 1-4
Jun 20, 2024
The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.
Prevalence of cardiovascular risk factors, diseases set to increase
Jun 06, 2024
The annual inflation-adjusted health care costs of cardiovascular risk factors is projected to triple between 2020 and 2050.
Semaglutide cuts risk for kidney outcomes, death in CKD with T2DM
May 31, 2024
A reduction was seen in risk for clinically important kidney outcomes and death from cardiovascular causes.
Diabetes increases risk for functional limitations in older adults
May 03, 2024
The findings were seen even after controlling for sociodemographic and other health factors.
ACP: Recommendations developed for newer type 2 diabetes medications
Apr 22, 2024
A strong recommendation was given for the addition of an SGLT-2 or GLP-1 agonist to metformin, and lifestyle modifications.
Coverage for Medicare’s e-visits still available, though few patients use service
By
Kristen Fischer
Apr 16, 2024
E-visits, which drew expanded coverage during the pandemic still are available but not used often, a new study shows.
2011 to 2020 saw increase in annual prescription meds expenditures
Apr 15, 2024
Metabolic agents were the most costly category; antidiabetic agents were the mostly costly therapeutic area.
ACC: Semaglutide beneficial in obesity-related heart failure, type 2 diabetes
Apr 09, 2024
Larger reductions were seen in heart failure-related symptoms and physical limitations for patients with HFpEF and type 2 diabetes.
Diabetes complications more common in patients not living in urban areas
Mar 27, 2024
The findings were seen for residents of remote areas and small towns compared with those living in cities.
